Selecta Biosciences: Q4 Earnings Insights
Selecta Biosciences (NASDAQ:SELB) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Preview: Selecta Biosciences
Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.07.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year.
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 7.38% to $1.6 during Thursday's after-market session. The market value of their outstanding shares is at $42.5 million.
